NASDAQ · STOCK
Cardinal Health
$230.01
52W $137.75 – $243.21
57/100
$53.87B
35.1
0.49
Is CAH Bullish or Bearish?
Mixed.
Innellis AI committee rates Cardinal Health (CAH) Watch with a composite score of 57/100
, based on 7 analysts with 57% agreement.
Last updated July 31, 2026.
What Would Change This View
- Upgrade to Buy
- Requires a committee score of 60.0 — +2.73 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Reduce
- Requires the score to fall below 40.0 — -17.27 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull & Bear Case
Bull Case
- ROE of 37.2% shows genuine earnings power backing the valuation — Value
- 4 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
- Weekly trend (uptrend) confirms the daily trend -- multi-timeframe agreement — Technical
- Market regime is bullish (Bull market -- normal position sizing) — Macro
Bear Case
- P/E of 34.4 is moderate-to-rich — Value
- Price-to-book of 9.2x prices in significant intangible value — Value
- Debt-to-equity of 3.48 adds balance-sheet risk to the value case — Value
- MACD histogram negative -- bearish momentum — Technical
- High leverage (debt-to-equity 3.48) amplifies downside in a stress scenario — Risk
- Current ratio of 0.94 is tight -- limited short-term liquidity cushion — Risk
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of July 31, 2026
Overall Committee Score
57/100
Agreement
57%
Analysts
7
Conviction
Contested
Sector Rank
Top 33%
of 93 Healthcare peers
Value Analyst
neutral
45
/ 100 · High confidence
Fair value -- neither a bargain nor obviously overpriced
+ ROE of 37.2% shows genuine earnings power backing the valuation
− P/E of 34.4 is moderate-to-rich
Growth Analyst
bullish
77
/ 100 · High confidence
Strong, accelerating growth with consistent execution
+ 4 consecutive earnings beats -- consistent execution
Technical Analyst
bullish
61
/ 100 · High confidence
Price action is constructive -- trend and momentum agree
+ Price structure making higher highs and higher lows
− MACD histogram negative -- bearish momentum
Risk Analyst
neutral
45
/ 100 · Moderate confidence
Moderate risk -- no single red flag, but nothing that clearly de-risks the position either
− High leverage (debt-to-equity 3.48) amplifies downside in a stress scenario
Macro Analyst
neutral
58
/ 100 · Moderate confidence
Macro backdrop is mixed or neutral -- not a strong tailwind or headwind either way
+ Market regime is bullish (Bull market -- normal position sizing)
News Analyst
bullish
70
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.40 across 68 articles, 14d)
Portfolio Manager
neutral
45
/ 100 · High confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− Sector concentration is already high (HHI 2744.14)
Investment Thesis Evolution
Committee score moved marginally from 55.9 to 57.3.
- New bearish signals: 3 appeared.
- Bullish support removed: 1 signal(s) disappeared.
- New bullish signals: 2 appeared.
- Bearish pressure eased: 3 signal(s) disappeared.
- Analyst(s) changed stance: Macro Analyst, Risk Analyst.
Analyst-level changes:
- Macro Analyst: stance bullish->neutral; score 65->58 (-8); +1 bullish signal(s).
- News Analyst: score 66->70 (+4); +1 bullish signal(s).
- Portfolio Manager: +2 bearish signal(s).
- Risk Analyst: stance bearish->neutral; score 32->45 (+12).
- Value Analyst: +1 bearish signal(s).
Comparing 2026-07-30 to 2026-07-31 (1 day apart).
Technical Analysis
RSI (14)
53.0
Neutral
MACD Histogram
-0.678
Bearish Momentum
Trend Direction
Uptrend
Weekly: Uptrend
Market Structure
Mixed
Support
$195.58
Resistance
$232.96
Bollinger %B
0.49
Inside Bands
Price vs Moving Averages
EMA 9
$228.78
Above
EMA 21
$228.50
Above
EMA 50
$223.30
Above
EMA 200
$204.42
Above
Fundamental Analysis
Valuation
40
Growth
93
Profitability
0
Financial Health
54
Cash Flow
37
Valuation
P/E Ratio
35.1×
P/B Ratio
-19.09×
PEG Ratio
17.34
Dividend Yield
0.01%
52W High
$243.21
52W Low
$137.75
Quality & Growth
ROE
-56.1%
ROA
2.9%
Gross Margin
3.7%
Operating Margin
0.9%
Revenue Growth YoY
—
Debt / Equity
-3.15
AI Fundamental Assessment
P/E ratio of 35.1 (rich relative to a 15-40x range); Price-to-book of -19.1x; PEG ratio of 17.3 (under 1.0 suggests growth is undervalued relative to price); Return on equity of -0.6%; Return on assets of 0.0%; Net margin of 0.0%; Gross margin of 0.0%; Current ratio of 0.91 (tight short-term liquidity); Debt-to-equity of -3.15; Free cash flow margin of 0.9% (thin cash generation); Free cash flow per share is positive (18.69); Most recent quarter beat estimates by 12.6%; 4 consecutive earnings beats; EPS growth accelerating (+3.1% -> +20.5% QoQ); Analyst estimates rising over recent quarters
Get the Full CAH Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →